/

/

/

Page 3

DrugCard - Pharmacovigilance Software

Year: 2025

“Ozempic Face” It’s More Than Just a Cosmetic Concern

Contact Lens Safety from a Pharmacovigilance Perspective

Masking of Personal Data in Pharmacovigilance

Drug Infusion Rate and How Speed Affects ADRs

Drug Discontinuation Needs More Attention in Drug Safety Monitoring

Precautionary Measures in PV Show How Safety Comes First

Nocebo Effect or When the Mind Becomes the Side Effect

Addendum to the Clinical Overview Supporting Safety Decisions

Foreign Language Syndrome or When ADRs Speak Another Language